Amplify Treatments Testing & Advancements ETF

GERM tracks a tier-weighted, narrow index of US-listed, global biotech companies that are engaged in the testing and treatments of infectious diseases.

GERM tracks a tier-weighted index of US-listed healthcare companies engaged in treatments, testing, and other medical advancements. Holdings are selected by the index committee.

Global X Telemedicine & Digital Health ETF

Global X Education ETF

Pacer BioThreat ETF

Direxion Work From Home ETF

The rest of 2021 is expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.

Are COVID-Themed ETFs Back in Focus as Delta Variant Fears Rise?

Annovis Bio

Arvinas Inc

Anavex Life Sciences

Virtus LifeSci Biotech Clinical Trials ETF

VanEck Vectors Biotech ETF

Virtus LifeSci Biotech Products ETF

Biohaven Pharmaceutical Hld

Biogen

Loncar Cancer Immunotherapy ETF

Denali Therapeutics

First Trust NYSE Arca Biotechnology Index Fund

Global X Genomics & Biotechnology ETF

abrdn Life Sciences Investors 

iShares Nasdaq Biotechnology ETF

Defiance Nasdaq Junior Biotechnology ETF

INmune Bio Inc

Intra-Cellular Therapies

Karuna Therapeutics Inc

Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

Eli Lilly

Invesco Dynamic Biotechnology & Genome ETF

Prothena

Cassava Sciences Inc

Supernus Pharmaceuticals

SPDR S&P Biotech ETF

Health Care Select Sector SPDR Fund

Biotechs are ready to march forcefully higher after a lengthy consolidation. Approval of Biogen's Alzheimer's treatment creates a bonanza for neurodegenerative-focused companies and the overall biotech sector.

Biotechs Ready To Roar

InfraCap MLP

Global X Copper Miners ETF

VanEck Vectors Steel ETF

Simplify Volt Cloud and Cybersecurity Disruption ETF

April proved to be the solid month for the U.S. stock market with all the three major indices hovering near record highs.

5 Sector ETFs That Crushed the Market in April

iShares U.S. Healthcare Providers ETF

Invesco S&P 500 Equal Weight Health Care ETF

ALPS Medical Breakthroughs ETF

ARK Genomic Revolution Multi-Sector ETF

The healthcare sector outperformed in the past year due to the pandemic. Here are seven ETFs for your portfolio to look beyond Covid-19.

7 Health-Focused ETFs To Buy Now For the Post-Covid Future

Arrow Dow Jones Global Yield ETF

VanEck Rare Earth/Strategic Metals ETF

Schwab U.S. Large-Cap Growth ETF

SPDR S&P Homebuilders ETF

ARK Industrial Innovation ETF

iShares US Infrastructure ETF

Here're seven of the most popular ETFs so far in 2021 The post The 7 Best-Performing ETFs Money Can Buy In 2021 appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn't matter if you have $500 in savings or $5 million.

The 7 Best-Performing ETFs Money Can Buy In 2021

Global X Lithium & Battery Tech ETF

Sprott Junior Gold Miners ETF

We have highlighted five ETFs from different zones that were at the heart of the latest market rally over the past week and will likely to do so if the current trends prevail.

5 Niche ETFs Dominating the Current Market Rally

Principal Healthcare Innovators Index ETF

Direxion Daily Healthcare Bull 3x Shares

Fidelity MSCI Health Care ETF

First Trust Nasdaq Pharmaceuticals ETF 

First Trust Health Care AlphaDEX Fund

abrdn Healthcare Investors 

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare ETF

John Hancock Multifactor Healthcare ETF

Global X Longevity Thematic ETF

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Invesco Dynamic Pharmaceuticals ETF

VanEck Vectors Pharmaceutical ETF

ProShares UltraShort Health Care

ProShares Ultra Health Care

Vanguard Health Care ETF

SPDR S&P Pharmaceuticals ETF

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of this year, as operations that were disrupted return to normal.

Biotech Innovations Remain At Forefront

Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12, 36% of the entire US population has received at least one vaccine, and 79% of those aged 65 years and older.

Moving Beyond COVID In Biopharma

Danaher

Gilead Sciences

Hologic

Immunovant Inc

Pfizer

Covid-19 has put healthcare stocks in the limelight. These seven companies should be on your radar for the next pandemic.

7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic

The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak considering the pandemic's renewed resurgence thanks to variants. Thus, a COVID-themed ETF could be a smart pick.

What's in Store for COVID-Themed ETFs as New Cases Rise?

iPath Bloomberg Commodity Index Total Return ETN

iPath Series B Bloomberg Natural Gas Subindex Total ReturnSM ETN 

iShares Russell 2000 ETF

Amplify Junior Silver Miners ETF

iShares MSCI Global Silver Miners ETF

Global X Data Center REITs & Digital Infrastructure ETF

The first month of 2021 was pretty volatile. While stocks were at their all-time highs in first part of January, some downbeat economic data points as well as the retail trading frenzy in some specific stocks in the month-end disbalanced the market momentum finally.

6 ETF Areas That Are on High Momentum

Amplify Video Game Tech ETF

Global X Cannabis ETF

The 3D Printing ETF

SPDR S&P Retail ETF

The three indices logged in their worst week since October, dropping more than 3% each, sending the Dow Jones and S&P 500 into the red for the first month of 2021.

5 Sector ETFs That Outperformed in a Volatile January

Biotech exchange-traded funds rallied Monday as investors continued to monitor the sector and its impact on the coronavirus pandemic. The ETFMG Treatments Testing and Advancement ETF gained 4.6% mid-morning, while the SPDR S&P Biotech ETF was up 2.4%.

Biotech ETFs extend January gains

The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.

COVID-Themed ETFs in Focus Amid Soaring Cases

iShares U.S. Oil Equipment & Services ETF

AdvisorShares Pure US Cannabis ETF

The S&P 500, the Dow Jones and the Nasdaq Composite -- all three indexes touched all-time closing highs to end last week.

Top Sector ETFs of Record-Setting Last Week

The rest of 2020 and the beginning of 2021 are expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.

COVID-Themed ETFs in Focus as Cases Soar Post Thanksgiving

There was big news on the coronavirus vaccine front Monday when Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) said their vaccine delivered an impressive showing in Phase 3 trials. What Happened: Alone, that news should have been a boon for exchange-traded funds such as the ETFMG Treatments, Testing and Advancements ETF (NYSE: GERM).

First Vaccine ETF Should See Halcyon Days Ahead

The remainder of 2020 is expected to continue bearing the brunt of the coronavirus outbreak and therefore, a COVID-19-themed ETF could be a smart pick.

Coronavirus-Themed ETFs in Focus as the Pandemic Worsens

Regeneron Pharmaceuticals

West Pharmaceutical Services

As the race to develop a vaccine continues, these biotech stocks could be high risk, high return propositions. The post 7 Biotech Stocks To Buy For Profit From The Vaccine Crunch appeared first on InvestorPlace.

7 Biotech Stocks To Buy For Profit From The Vaccine Crunch

It feels like the rest of 2020 will continue to bear the brunt of the coronavirus outbreak and therefore, a COVID-19-themed ETF could be a smart pick.

5 Coronavirus-Themed ETFs That Can Fight the Pandemic Scares

AstraZeneca

iShares U.S. Home Construction ETF

iShares Global Materials ETF

iShares MSCI Global Gold Miners ETF

Invesco Solar ETF

Amid the uncertainties, a few sectors have survived last week's turmoil. We have highlighted six of that could be compelling picks for the weeks ahead as long as volatility persists.

6 Sector ETFs Surviving the Market Rout

There are advantages -- and disadvantages -- to some of the newest ETFs on the market.

Should You Invest in Coronavirus ETFs?

In the current scenario of the rising work-from-home and online shopping trends, online learning, home entertainment, telemedicine and digital health services are slowly becoming the "new normal."

Direxion Debuts CCON ETF, Expands COVID-19-Themed Product Base

iShares Genomics Immunology and Healthcare ETF

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.

Moderna ETFs to Gain on New Positive COVID-19 Vaccine Data

Direxion Debuts CCOC ETF, Expands COVID-19-Themed Product Base

News for Amplify Treatments Testing & Advancements ETF ETF (GERM)